The female and the fragile X reviewed

Semin Reprod Med. 2001 Jun;19(2):159-65. doi: 10.1055/s-2001-15401.

Abstract

Nearly 15 years ago, female carriers of the fragile X mental retardation syndrome were noted to have an increased incidence of twin pregnancies. Since then, much evidence has accumulated supporting the notion of ovarian dysfunction in fragile X carriers, in the forms of increased dizygotic twinning and premature ovarian failure. However, despite a decade and a half of research regarding this association, the underlying mechanism remains a mystery. This article reviews the population-based studies that have examined this association and discusses possible reasons for the variations in results. In addition, results from more recent studies on endocrine function in fragile X carriers are discussed. These data, when considered in conjunction with our emerging understanding of the molecular biology of the fragile X gene (FMR1) and its protein product (FMRP), are beginning to elucidate possible mechanisms for the association between fragile X syndrome and ovarian dysfunction.

Publication types

  • Review

MeSH terms

  • Chromosome Fragility / genetics
  • Female
  • Fragile X Mental Retardation Protein
  • Fragile X Syndrome / complications*
  • Fragile X Syndrome / genetics*
  • Fragile X Syndrome / metabolism
  • Fragile X Syndrome / physiopathology
  • Heterozygote
  • Humans
  • Models, Biological
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Primary Ovarian Insufficiency / complications*
  • Primary Ovarian Insufficiency / genetics*
  • Primary Ovarian Insufficiency / metabolism
  • Primary Ovarian Insufficiency / physiopathology
  • RNA-Binding Proteins*
  • Twins / genetics
  • X Chromosome / genetics*

Substances

  • FMR1 protein, human
  • Nerve Tissue Proteins
  • RNA-Binding Proteins
  • Fragile X Mental Retardation Protein